<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>贝壳社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-29T16:41:39+08:00</updated>
  <subtitle>贝壳社是国内领先的医疗健康创新创业服务平台，集聚政府、上市公司、投资机构和三甲医院等产业高端资源，提供一站式的全球生命健康人才项目引进、转化孵化和产业化等全产业链协同创新和赋能服务。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>恒瑞、信达、君实、百济PD-1谁的销量高？谁能取胜药价谈判？谁的适应症多？谁进治疗指南多？PD-(L)1价格战已在途！</title>
    <updated>2020-11-27T20:15:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Z-1DPv_OYKlOuM1epkNClQ</id>
    <link href="https://mp.weixin.qq.com/s/Z-1DPv_OYKlOuM1epkNClQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来、辉瑞、罗氏纷纷布局，基因疗法能否为这种罕见病带来曙光？</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/4_OfUNygw49Sk-gIVZ7yvQ</id>
    <link href="https://mp.weixin.qq.com/s/4_OfUNygw49Sk-gIVZ7yvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>581天同行：在变化中成长，在坚持中蜕变 | 贝壳大学三期毕业典礼圆满召开</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Y-O7Wp62Dqm7AwLyU-zx4g</id>
    <link href="https://mp.weixin.qq.com/s/Y-O7Wp62Dqm7AwLyU-zx4g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干细胞治疗新冠相关呼吸疾病，诺华达成13.5亿美元协议；医院发布：限制非基药使用 | 贝壳日报</title>
    <updated>2020-11-27T20:06:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/BKYJ4PE1G2zrjNfixMeZMQ</id>
    <link href="https://mp.weixin.qq.com/s/BKYJ4PE1G2zrjNfixMeZMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>三代试管婴儿法规监管里程碑：首个“有证”PGS试剂盒亮相中华医学会2020生殖医学年会</title>
    <updated>2020-11-26T09:47:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/0tYBVLycC8xhWBV0r5rfRQ</id>
    <link href="https://mp.weixin.qq.com/s/0tYBVLycC8xhWBV0r5rfRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向p53突变，潜在新药启动临床试验；Ebiomedicine: 新研究有助于治疗炎症反应 | 贝壳日报</title>
    <updated>2020-11-26T09:47:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/LTS2c7IaNgBlLpuPXDQyTA</id>
    <link href="https://mp.weixin.qq.com/s/LTS2c7IaNgBlLpuPXDQyTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>启动“细胞药物研发生产基地”，牵手基因与细胞治疗CDMO龙头，羿尊生物驶入发展快车道</title>
    <updated>2020-11-25T11:19:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/hMpeUYzL_Duzk2kb0yLomg</id>
    <link href="https://mp.weixin.qq.com/s/hMpeUYzL_Duzk2kb0yLomg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个早衰症治疗药物获FDA批准，死亡率降低77％；圣和药业丙肝1类新药拟纳入优先审评 | 贝壳日报</title>
    <updated>2020-11-25T11:19:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/D7N8gjB2cn2OfgYLBJLnnA</id>
    <link href="https://mp.weixin.qq.com/s/D7N8gjB2cn2OfgYLBJLnnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TAVR在美国的发展现状</title>
    <updated>2020-11-24T17:23:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/cOq_1m7HK5o2Yph1EOr64Q</id>
    <link href="https://mp.weixin.qq.com/s/cOq_1m7HK5o2Yph1EOr64Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和铂医药通过港交所聆讯，多产品线拓展，六项进入临床阶段</title>
    <updated>2020-11-24T17:23:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/D1P31UZyOgOdIRF9lX-9fg</id>
    <link href="https://mp.weixin.qq.com/s/D1P31UZyOgOdIRF9lX-9fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关注！TCR疗法喜迎首个积极3期结果，显著提高总生存率；默沙东拟收购昂科免疫，囊获新冠创新疗法 | 贝壳日报</title>
    <updated>2020-11-24T17:23:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/5LHZcdG2TP8KtSLGd_5B-g</id>
    <link href="https://mp.weixin.qq.com/s/5LHZcdG2TP8KtSLGd_5B-g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杨青：机会只偏爱那些看得见特殊信号的人</title>
    <updated>2020-11-23T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/kstFaEdvi0zWhHcvZY6QsQ</id>
    <link href="https://mp.weixin.qq.com/s/kstFaEdvi0zWhHcvZY6QsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！2020年全球医疗器械企业100强出炉！</title>
    <updated>2020-11-23T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/8KttrRnc_OkqP6tAS2TRmA</id>
    <link href="https://mp.weixin.qq.com/s/8KttrRnc_OkqP6tAS2TRmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新药新锐Bionova Pharmaceuticals（烨辉医药）宣布完成B+轮融资</title>
    <updated>2020-11-23T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/Kf_7qEoQ0rpORsZiexTLRQ</id>
    <link href="https://mp.weixin.qq.com/s/Kf_7qEoQ0rpORsZiexTLRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>获优先审评资格，首款靶向CD19的ADC有望问世；FDA批准首个早衰症疗法 | 贝壳日报</title>
    <updated>2020-11-23T17:30:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/8OTQIBnquNAewj0PUMWXpg</id>
    <link href="https://mp.weixin.qq.com/s/8OTQIBnquNAewj0PUMWXpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA：9个突破性医疗器械，展示了怎样的未来医疗方向</title>
    <updated>2020-11-20T19:38:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/3B64mE8z5iFj_s9V1fkg1A</id>
    <link href="https://mp.weixin.qq.com/s/3B64mE8z5iFj_s9V1fkg1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！德琪医药港股上市，市值超120亿港元</title>
    <updated>2020-11-20T11:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Dlum1R1lRChKk8n3FwBq6A</id>
    <link href="https://mp.weixin.qq.com/s/Dlum1R1lRChKk8n3FwBq6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【报名即将截止】最终议程大公开！3大主题论坛，35+话题覆盖抗体开发与工艺生产，40+生物药大咖邀您共聚金陵城！</title>
    <updated>2020-11-20T11:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/0ka7XraSGJlSDvRQplisnQ</id>
    <link href="https://mp.weixin.qq.com/s/0ka7XraSGJlSDvRQplisnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第三款RNAi药物今日获欧盟批准；流感高发季，省级卫健委跟进发布诊疗方案，多个药品被推荐 | 贝壳日报</title>
    <updated>2020-11-20T11:30:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/a_Pe2s-mkxBYd0nj7z7NaQ</id>
    <link href="https://mp.weixin.qq.com/s/a_Pe2s-mkxBYd0nj7z7NaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature最新研究｜通过长达10年时间监测，被公认为安全的AAV载体存在潜在致癌性</title>
    <updated>2020-11-19T18:18:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/g5eZpbjoMyvTmf_v831w9g</id>
    <link href="https://mp.weixin.qq.com/s/g5eZpbjoMyvTmf_v831w9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>